Company: CPMV
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001683168-25-002584
Chunk: 33

Company: Mosaic ImmunoEngineering Inc.
Filing Date: 2025-04-15
Form: 10-K
Item: Item 1
Chunk 33
---
 industry is intense, competitors
may infringe or otherwise violate potential rights to patents of our licensors or other intellectual property that we may license or acquire
in the future. If we are able to raise sufficient capital and potentially license or acquire new technologies, in order to counter infringement
or unauthorized use, we may be required to file infringement claims, which can be expensive and time-consuming. Any claims we assert against
perceived infringers could provoke these parties to assert counterclaims against us alleging that we infringe their patents. In addition,
in a patent infringement proceeding, a court may decide that a patent of ours is invalid or unenforceable, in whole or in part, construe
the patent’s claims narrowly, or refuse to stop the other party from using the technology at issue on the grounds that our patents
do not cover the technology in question. An adverse result in any litigation proceeding could put one or more of our potential patents
at risk of being invalidated or interpreted narrowly. We may also elect to enter into license agreements in order to settle patent infringement
claims or to resolve disputes prior to litigation, and any such license agreement may require us to pay royalties and other fees that
could be significant. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation,
there is a risk that some of our confidential information could be compromised by disclosure.

 19 

We may need to license certain intellectual property
from third parties, and such licenses may not be available or may not be available on commercially reasonable terms. 

If we are able to raise sufficient capital and potentially
license or acquire new technologies, a third party may hold intellectual property, including patent rights that are important or necessary
to the development of potential new technologies or products we may license or acquire. It may be necessary for us to use the patented
or proprietary technology of third parties to commercialize potential products, in which case, we would be required to obtain a license
from these third parties on commercially reasonable terms, or our business could be harmed, possibly materially. If we were not able to
obtain a license, or we are not able to obtain a license on commercially reasonable terms, our business could be harmed, possibly materially.

Third parties may initiate legal proceedings alleging
that we are infringing their intellectual property rights, the outcome of which would be uncertain and could have a material adverse effect
on the success of our business. 

If we are able to raise sufficient capital and potentially
license or acquire new technologies, then our